Prader-Willi Syndrome and PCSK1 mutation: a novel presentation of combined syndromic and monogenic obesity.

Kostopoulou, E; Spilioti, D X; Pantzaris, N D; Spiliotis, B E

Kostopoulou, E; Spilioti, D X; Pantzaris, N D; Spiliotis, B E.

Affiliation

Kostopoulou E; Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, University of Patras School of Medicine, Patras, Greece. spilioti@upatras.gr.

Eur Rev Med Pharmacol Sci ; 26(7): 2437-2442, 2022 04.

Article in En | MEDLINE | ID: mdl-35442499

Subject(s)

Prader-Willi Syndrome; Adult; Genomic Imprinting; High-Throughput Nucleotide Sequencing; Humans; Male; Mutation; Prader-Willi Syndrome/diagnosis; Prader-Willi Syndrome/genetics; Prader-Willi Syndrome/metabolism; Proprotein Convertase 1/genetics; Proprotein Convertase 1/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prader-Willi Syndrome Type of study: Diagnostic_studies Limits: Adult / Humans / Male Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2022 Document type: Article Affiliation country: Greece

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google